SS-31 – ≥99% Purity | Research-Grade Standard

High-Purity Synthetic Mitochondrial-Targeted Peptide for Laboratory Research

SS-31 (Elamipretide) is supplied as a sterile, lyophilized white to off-white powder. Each production lot undergoes comprehensive analytical verification to confirm identity and purity (≥99%) prior to release.

Technical Specifications

Synonyms: Elamipretide; MTP-131; Szeto–Schiller Peptide 31
CAS Number: 897016-82-9
Molecular Formula: C₄₉H₆₂N₁₂O₉S₂
Molecular Weight: 1,005.2 g/mol
Peptide Length: 4 amino acids (aromatic-cationic tetrapeptide)
Purity: ≥99.0% (validated by Certificate of Analysis)
Appearance: White to off-white lyophilized powder
Solubility: Freely soluble in sterile water (H₂O) or bacteriostatic water
Analytical Verification: Confirmed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry
Endotoxin Status: Verified LPS-free (batch tested)
Storage Conditions: Store dry at 2–8 °C
Reconstituted Stability: Refrigerate and use within 6 weeks

Quality Assurance

Manufactured in a GMP-compliant, ISO 9001:2008-certified facility.

Each batch undergoes comprehensive quality control procedures, including:

• Identity verification

• Purity confirmation (≥99%)

• RP-HPLC chromatographic analysis

• Mass spectrometric validation

• Endotoxin screening

A batch-specific Certificate of Analysis (CoA) is available upon request.

Intended Use & Research Disclaimer

This product is supplied strictly for scientific research and laboratory use only.

• Not for human or veterinary use

• Not intended for therapeutic or diagnostic applications

• Not approved by any regulatory authority

• Not for use as a drug, food, cosmetic, or household product

By purchasing or handling this material, the buyer acknowledges that this compound is an investigational research chemical. The purchaser assumes full responsibility for proper handling, storage, and use in compliance with all applicable laws and safety standards.

No representations or warranties are made regarding biological activity, therapeutic benefit, or suitability outside of controlled research environments.